Showing results (731-740 of 944) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|May 21, 2025
Disease Course in Patients Switched from Natalizumab to Alemtuzumab: An Italian Multicenter, Prospective, Observational StudySimona Malucchi, Paola Perini, Francesca Rinaldi, et al.Neurology and Therapy|June 10, 2025
Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson's Disease: A Swedish Study on Real-World Use and CostsPer Odin, Christoffer Tærud, Jenny Samuelsson, et al.Neurology and Therapy|June 9, 2025
Dysphagia Management is Associated with Reduced Mortality in Patients with Moderate to Severe Acute Ischemic StrokeJulian Frederic Hotz, Lisa Kaindl, Lisa Schneider, et al.Neurology and Therapy|June 11, 2025
Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST TrialRajesh Pahwa, Eric Molho, Mark Lew, et al.Neurology and Therapy|May 13, 2025
Understanding the Patient Experience of Advanced Parkinson's Disease: Qualitative Research with Patients and Expert Clinicians to Identify Symptoms and Associated Health-Related Quality of Life ImpactsNicola Williamson, Thomas Morel, Helena Bradley, et al.Neurology and Therapy|May 13, 2025
Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic NeuropathyLi Li, Xueqin Luo, Yong Liu, et al.Neurology and Therapy|March 27, 2025
Understanding Depression in People Living with Multiple Sclerosis: A Narrative Review of Recent LiteratureAmy B Sullivan, Bryan Davis, Julie Kidd, et al.Neurology and Therapy|March 21, 2025
Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World DataDag Nyholm, Simon Eggington, Astrid HolmNeurology and Therapy|November 28, 2017
A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate SchizophreniaDavid Brown, Kristen Daniels, Solen Pichereau, et al.Neurology and Therapy|December 10, 2017
Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory MedicineDaniel Kantor, Jeremy R Bright, Jeri BurtchellPageof 95